Ciprofloxacin resistance in Neisseria meningitidis, France.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed, 44 citations in OpenAlex.

1. Assessment of Knowledge Regarding Safety Profile, Use, and Boxed Warnings of Fluoroquinolones Among Healthcare Professionals in Saudi Arabia: A Potential Implication for Drug Regulatory Authorities.Frontiers in medicine · 2022
   Article
2. Susceptibilities of invasiveJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2021
   Article
3. Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010/11 to 2018/19).PloS one · 2021
   Article
4. The spread of chloramphenicol-resistant Neisseria meningitidis in Southeast Asia.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
   Article
5. Calculated parenteral initial therapy of bacterial infections: Bacterial meningitis.GMS infectious diseases · 2020
   Article
6. Mass chemoprophylaxis for control of outbreaks of meningococcal disease.The Lancet. Infectious diseases · 2018
   Review
7. Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States.Open forum infectious diseases · 2015
   Article
8. Shifts in the Antibiotic Susceptibility, Serogroups, and Clonal Complexes of Neisseria meningitidis in Shanghai, China: A Time Trend Analysis of the Pre-Quinolone and Quinolone Eras.PLoS medicine · 2015
   Article
9. Phasevarions mediate epigenetic regulation of antimicrobial susceptibility in Neisseria meningitidis.Antimicrobial agents and chemotherapy · 2014
   Article
10. Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin.Antimicrobial agents and chemotherapy · 2013
    Article
11. Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010.PloS one · 2013
    Article
12. Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.Infection · 2012
    Review
13. Evolutionary changes in antimicrobial resistance of invasive Neisseria meningitidis isolates in Belgium from 2000 to 2010: increasing prevalence of penicillin nonsusceptibility.Antimicrobial agents and chemotherapy · 2012
    Article
14. Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.Antimicrobial agents and chemotherapy · 2010
    Article
15. Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.Antimicrobial agents and chemotherapy · 2009
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 2 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as